SCHEMBL6206487

SCHEMBL6206487

CC(=O)Sc1cccs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11181263 0.98 FBP1 (0.48)
SCHEMBL6532776 0.82 FBP1 (0.54)
SCHEMBL10709338 0.80 FBP1 (0.43)
SCHEMBL9586347 0.80
SCHEMBL3070412 0.78
SCHEMBL27632300 0.78 FBP1 (0.45)
SCHEMBL11327639 0.77 FBP1 (0.48)
Potassium Ion SCHEMBL11192203 0.77 FBP1 (0.48)
SCHEMBL4339783 0.75 FBP1 (0.42)
SCHEMBL28983778 0.74 HPGDS (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1565459-A2 HETEROARYLSULFONYLMETHYL HYDROXAMIC ACIDS AND AMIDES AND THEIR USE AS PROTEASE INHIBITORS Pharmacia Corporation (US) 2005-08-24 EP disclosed
WO-2004048368-A2 HETEROARYLSULFONYLMETHYL HYDROXAMIC ACIDS AND AMIDES AND THEIR USE AS PROTEASE INHIBITORS PHARMACIA CORPORATION (US) 2004-06-10 WO disclosed
EP-0361961-B1 Organic componds and their use as pharmaceuticals LILLY SA (ES) 1994-02-02 EP disclosed
US-5041461-A Organic compounds and their use as pharmaceuticals LILLY INDUSTRIES LIMITED (GB) 1991-08-20 US disclosed
EP-0361961-A1 Organic componds and their use as pharmaceuticals LILLY S.A. (ES) 1990-04-04 EP disclosed